Epidemiology

  1. Initial Simulation of SARS-CoV2 Spread and Intervention Effects in the Continental US

    1. Sen Pei
    2. Jeffrey Shaman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. A Vulnerability Analysis for the Management of and Response to the COVID-19 Epidemic in the Second Most Populous State in Brazil

    1. Igor Silva Campos
    2. Vinícius Ferreira Aratani
    3. Karina Baltor Cabral
    4. Jean Ezequiel Limongi
    5. Stefan Vilges de Oliveira

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Trend analysis of the COVID-19 pandemic in China and the rest of the world

    1. Albertine Weber
    2. Flavio Iannelli
    3. Sebastián Gonçalves

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Modelling for prediction of the spread and severity of COVID-19 and its association with socioeconomic factors and virus types

    1. Rakesh Tuli
    2. Shreshth Tuli
    3. Shikhar Tuli
    4. Ruchi Verma

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey*

    1. S.K. Mahil
    2. M. Yates
    3. S.M. Langan
    4. Z.Z.N. Yiu
    5. T. Tsakok
    6. N. Dand
    7. K.J. Mason
    8. H. McAteer
    9. F. Meynell
    10. B. Coker
    11. A. Vincent
    12. D. Urmston
    13. A. Vesty
    14. J. Kelly
    15. C. Lancelot
    16. L. Moorhead
    17. H. Bachelez
    18. I.N. Bruce
    19. F. Capon
    20. C.R. Contreras
    21. A.P. Cope
    22. C. De La Cruz
    23. P. Di Meglio
    24. P. Gisondi
    25. K. Hyrich
    26. D. Jullien
    27. J. Lambert
    28. H. Marzo‐Ortega
    29. I. McInnes
    30. L. Naldi
    31. S. Norton
    32. L. Puig
    33. R. Sengupta
    34. P. Spuls
    35. T. Torres
    36. R.B. Warren
    37. H. Waweru
    38. J. Weinman
    39. C.E.M. Griffiths
    40. J.N. Barker
    41. M.A. Brown
    42. J.B. Galloway
    43. C.H. Smith
    44. the PsoProtect, CORE‐UK study groups

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis

    1. Aaron Leong
    2. Joanne B. Cole
    3. Laura N. Brenner
    4. James B. Meigs
    5. Jose C. Florez
    6. Josep M. Mercader

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

    1. Kathy Leung
    2. Marcus HH Shum
    3. Gabriel M Leung
    4. Tommy TY Lam
    5. Joseph T Wu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study

    1. Ju Hwan Kim
    2. Yeon-Hee Baek
    3. Hyesung Lee
    4. Young June Choe
    5. Hyun Joon Shin
    6. Ju-Young Shin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Theoretical Epidemic Laws Based on Data of COVID-19 Pandemic

    1. Junke Guo

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Regional COVID-19 spread despite expected declines: how mitigation is hindered by spatio-temporal variation in local control measures

    1. Nicholas Kortessis
    2. Margaret W. Simon
    3. Michael Barfield
    4. Gregory Glass
    5. Burton H. Singer
    6. Robert D. Holt

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 247 of 463 Next